跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fozal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Fozal
Approved
STANDARD
Fozal
Sun Pharmaceutical Industries Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dfa7489595d62319
Company
Sun Pharmaceutical Industries Ltd.
Type
Standard
Approval Details
Approval Id
dfa7489595d62319
Drug Approval Philippines Name
Fozal
Product Name
Fozal
Registration Number
DR-XY35249
Brand Name
Fozal
Generic Name
Alfuzosin Hydrochloride
Dosage Form
Modified-Release Tablet
Dosage Strength
10 mg
Manufacturer
Sun Pharmaceutical Industries Ltd.
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Company Detail Path
/organization/sun-pharmaceutical-industries-ltd
Issuance Date
28 June 2023
Expiry Date
19 December 2028
Pharmacologic Category
Alpha-Adrenoreceptor Antagonists
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dfa7489595d62319
Type
Standard
Back to Philippines FDA Approvals